Global Immune Cell Therapy Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global Immune Cell Therapy Market Insights, Forecast to 2034

Immune Cell Therapy is a medical treatment approach that involves modifying a patient's own immune cells, typically T cells, to enhance their ability to recognize and attack cancer cells or other diseases.
Market Analysis and InsightsGlobal Immune Cell Therapy Market
Global Immune Cell Therapy market is expected to reach to US$ 4214 million in 2023, with a positive growth of %, compared with US$ 3435 million in 2023 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Immune Cell Therapy industry is evaluated to reach US$ 15060 million in 2033. The CAGR will be 23.7% during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2023, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2023. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2023. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Immune Cell Therapy market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Immune Cell Therapy market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report

By Company

Adaptimmune
Altor Bioscience Corporation
Cellectis
Juno Therapeutics
Kite Pharma
Novartis
Takara Bio
Unum Therapeutics
Segment by Type
T Cell Therapy
Natural Killer (NK) Cell Therapy
Other

Segment by Application

Stomach Cancer
Lung Cancer
Colorectal Cancer
Esophageal Cancer
Pancreatic Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline

Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Immune Cell Therapy introduction, etc. Immune Cell Therapy Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRA Research’s Conclusions of Immune Cell Therapy
Chapter 13Methodology and Data Sources adopted by MRA Research

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immune Cell Therapy Market Size Growth Rate by Type, 2018 VS 2023 VS 2033
1.2.2 T Cell Therapy
1.2.3 Natural Killer (NK) Cell Therapy
1.2.4 Other
1.3 Market by Application
1.3.1 Global Immune Cell Therapy Market Size Growth Rate by Application, 2018 VS 2023 VS 2033
1.3.2 Stomach Cancer
1.3.3 Lung Cancer
1.3.4 Colorectal Cancer
1.3.5 Esophageal Cancer
1.3.6 Pancreatic Cancer
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immune Cell Therapy Market Perspective (2018-2033)
2.2 Global Immune Cell Therapy Growth Trends by Region
2.2.1 Immune Cell Therapy Market Size by Region: 2018 VS 2023 VS 2033
2.2.2 Immune Cell Therapy Historic Market Size by Region (2018-2023)
2.2.3 Immune Cell Therapy Forecasted Market Size by Region (2024-2033)
2.3 Immune Cell Therapy Market Dynamics
2.3.1 Immune Cell Therapy Industry Trends
2.3.2 Immune Cell Therapy Market Drivers
2.3.3 Immune Cell Therapy Market Challenges
2.3.4 Immune Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Immune Cell Therapy by Players
3.1.1 Global Immune Cell Therapy Revenue by Players (2018-2023)
3.1.2 Global Immune Cell Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Immune Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Immune Cell Therapy, Ranking by Revenue, 2021 VS 2023 VS 2023
3.4 Global Immune Cell Therapy Market Concentration Ratio
3.4.1 Global Immune Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immune Cell Therapy Revenue in 2023
3.5 Global Key Players of Immune Cell Therapy Head office and Area Served
3.6 Global Key Players of Immune Cell Therapy, Product and Application
3.7 Global Key Players of Immune Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Immune Cell Therapy Breakdown Data by Type
4.1 Global Immune Cell Therapy Historic Market Size by Type (2018-2023)
4.2 Global Immune Cell Therapy Forecasted Market Size by Type (2024-2033)
5 Immune Cell Therapy Breakdown Data by Application
5.1 Global Immune Cell Therapy Historic Market Size by Application (2018-2023)
5.2 Global Immune Cell Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Immune Cell Therapy Market Size (2018-2033)
6.2 North America Immune Cell Therapy Market Size by Type
6.2.1 North America Immune Cell Therapy Market Size by Type (2018-2023)
6.2.2 North America Immune Cell Therapy Market Size by Type (2024-2033)
6.2.3 North America Immune Cell Therapy Market Share by Type (2018-2033)
6.3 North America Immune Cell Therapy Market Size by Application
6.3.1 North America Immune Cell Therapy Market Size by Application (2018-2023)
6.3.2 North America Immune Cell Therapy Market Size by Application (2024-2033)
6.3.3 North America Immune Cell Therapy Market Share by Application (2018-2033)
6.4 North America Immune Cell Therapy Market Size by Country
6.4.1 North America Immune Cell Therapy Market Size by Country: 2018 VS 2023 VS 2033
6.4.2 North America Immune Cell Therapy Market Size by Country (2018-2023)
6.4.3 North America Immune Cell Therapy Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Immune Cell Therapy Market Size (2018-2033)
7.2 Europe Immune Cell Therapy Market Size by Type
7.2.1 Europe Immune Cell Therapy Market Size by Type (2018-2023)
7.2.2 Europe Immune Cell Therapy Market Size by Type (2024-2033)
7.2.3 Europe Immune Cell Therapy Market Share by Type (2018-2033)
7.3 Europe Immune Cell Therapy Market Size by Application
7.3.1 Europe Immune Cell Therapy Market Size by Application (2018-2023)
7.3.2 Europe Immune Cell Therapy Market Size by Application (2024-2033)
7.3.3 Europe Immune Cell Therapy Market Share by Application (2018-2033)
7.4 Europe Immune Cell Therapy Market Size by Country
7.4.1 Europe Immune Cell Therapy Market Size by Country: 2018 VS 2023 VS 2033
7.4.2 Europe Immune Cell Therapy Market Size by Country (2018-2023)
7.4.3 Europe Immune Cell Therapy Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Immune Cell Therapy Market Size (2018-2033)
8.2 China Immune Cell Therapy Market Size by Type
8.2.1 China Immune Cell Therapy Market Size by Type (2018-2023)
8.2.2 China Immune Cell Therapy Market Size by Type (2024-2033)
8.2.3 China Immune Cell Therapy Market Share by Type (2018-2033)
8.3 China Immune Cell Therapy Market Size by Application
8.3.1 China Immune Cell Therapy Market Size by Application (2018-2023)
8.3.2 China Immune Cell Therapy Market Size by Application (2024-2033)
8.3.3 China Immune Cell Therapy Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Immune Cell Therapy Market Size (2018-2033)
9.2 Asia Immune Cell Therapy Market Size by Type
9.2.1 Asia Immune Cell Therapy Market Size by Type (2018-2023)
9.2.2 Asia Immune Cell Therapy Market Size by Type (2024-2033)
9.2.3 Asia Immune Cell Therapy Market Share by Type (2018-2033)
9.3 Asia Immune Cell Therapy Market Size by Application
9.3.1 Asia Immune Cell Therapy Market Size by Application (2018-2023)
9.3.2 Asia Immune Cell Therapy Market Size by Application (2024-2033)
9.3.3 Asia Immune Cell Therapy Market Share by Application (2018-2033)
9.4 Asia Immune Cell Therapy Market Size by Region
9.4.1 Asia Immune Cell Therapy Market Size by Region: 2018 VS 2023 VS 2033
9.4.2 Asia Immune Cell Therapy Market Size by Region (2018-2023)
9.4.3 Asia Immune Cell Therapy Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Immune Cell Therapy Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Immune Cell Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Immune Cell Therapy Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Immune Cell Therapy Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Immune Cell Therapy Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Immune Cell Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Immune Cell Therapy Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Immune Cell Therapy Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Immune Cell Therapy Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Immune Cell Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Immune Cell Therapy Market Size by Country: 2018 VS 2023 VS 2033
10.4.2 Middle East, Africa, and Latin America Immune Cell Therapy Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Immune Cell Therapy Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Adaptimmune
11.1.1 Adaptimmune Company Details
11.1.2 Adaptimmune Business Overview
11.1.3 Adaptimmune Immune Cell Therapy Introduction
11.1.4 Adaptimmune Revenue in Immune Cell Therapy Business (2018-2023)
11.1.5 Adaptimmune Recent Developments
11.2 Altor Bioscience Corporation
11.2.1 Altor Bioscience Corporation Company Details
11.2.2 Altor Bioscience Corporation Business Overview
11.2.3 Altor Bioscience Corporation Immune Cell Therapy Introduction
11.2.4 Altor Bioscience Corporation Revenue in Immune Cell Therapy Business (2018-2023)
11.2.5 Altor Bioscience Corporation Recent Developments
11.3 Cellectis
11.3.1 Cellectis Company Details
11.3.2 Cellectis Business Overview
11.3.3 Cellectis Immune Cell Therapy Introduction
11.3.4 Cellectis Revenue in Immune Cell Therapy Business (2018-2023)
11.3.5 Cellectis Recent Developments
11.4 Juno Therapeutics
11.4.1 Juno Therapeutics Company Details
11.4.2 Juno Therapeutics Business Overview
11.4.3 Juno Therapeutics Immune Cell Therapy Introduction
11.4.4 Juno Therapeutics Revenue in Immune Cell Therapy Business (2018-2023)
11.4.5 Juno Therapeutics Recent Developments
11.5 Kite Pharma
11.5.1 Kite Pharma Company Details
11.5.2 Kite Pharma Business Overview
11.5.3 Kite Pharma Immune Cell Therapy Introduction
11.5.4 Kite Pharma Revenue in Immune Cell Therapy Business (2018-2023)
11.5.5 Kite Pharma Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Immune Cell Therapy Introduction
11.6.4 Novartis Revenue in Immune Cell Therapy Business (2018-2023)
11.6.5 Novartis Recent Developments
11.7 Takara Bio
11.7.1 Takara Bio Company Details
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio Immune Cell Therapy Introduction
11.7.4 Takara Bio Revenue in Immune Cell Therapy Business (2018-2023)
11.7.5 Takara Bio Recent Developments
11.8 Unum Therapeutics
11.8.1 Unum Therapeutics Company Details
11.8.2 Unum Therapeutics Business Overview
11.8.3 Unum Therapeutics Immune Cell Therapy Introduction
11.8.4 Unum Therapeutics Revenue in Immune Cell Therapy Business (2018-2023)
11.8.5 Unum Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Immune Cell Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2023 VS 2033
Table 2. Key Players of T Cell Therapy
Table 3. Key Players of Natural Killer (NK) Cell Therapy
Table 4. Key Players of Other
Table 5. Global Immune Cell Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2023 VS 2033
Table 6. Global Immune Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 7. Global Immune Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Immune Cell Therapy Market Share by Region (2018-2023)
Table 9. Global Immune Cell Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Immune Cell Therapy Market Share by Region (2024-2033)
Table 11. Immune Cell Therapy Market Trends
Table 12. Immune Cell Therapy Market Drivers
Table 13. Immune Cell Therapy Market Challenges
Table 14. Immune Cell Therapy Market Restraints
Table 15. Global Immune Cell Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Immune Cell Therapy Revenue Share by Players (2018-2023)
Table 17. Global Top Immune Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Cell Therapy as of 2023)
Table 18. Global Immune Cell Therapy Industry Ranking 2021 VS 2023 VS 2023
Table 19. Global 5 Largest Players Market Share by Immune Cell Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Immune Cell Therapy, Headquarters and Area Served
Table 21. Global Key Players of Immune Cell Therapy, Product and Application
Table 22. Global Key Players of Immune Cell Therapy, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Immune Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Immune Cell Therapy Revenue Market Share by Type (2018-2023)
Table 26. Global Immune Cell Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Immune Cell Therapy Revenue Market Share by Type (2024-2033)
Table 28. Global Immune Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Immune Cell Therapy Revenue Share by Application (2018-2023)
Table 30. Global Immune Cell Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Immune Cell Therapy Revenue Share by Application (2024-2033)
Table 32. North America Immune Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Immune Cell Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America Immune Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Immune Cell Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America Immune Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 37. North America Immune Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Immune Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Immune Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Immune Cell Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe Immune Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Immune Cell Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe Immune Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 44. Europe Immune Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Immune Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 46. China Immune Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Immune Cell Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 48. China Immune Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Immune Cell Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia Immune Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Immune Cell Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia Immune Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Immune Cell Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Immune Cell Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 55. Asia Immune Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Immune Cell Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Immune Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Immune Cell Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Immune Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Immune Cell Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Immune Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 62. Middle East, Africa, and Latin America Immune Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Immune Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 64. Adaptimmune Company Details
Table 65. Adaptimmune Business Overview
Table 66. Adaptimmune Immune Cell Therapy Product
Table 67. Adaptimmune Revenue in Immune Cell Therapy Business (2018-2023) & (US$ Million)
Table 68. Adaptimmune Recent Developments
Table 69. Altor Bioscience Corporation Company Details
Table 70. Altor Bioscience Corporation Business Overview
Table 71. Altor Bioscience Corporation Immune Cell Therapy Product
Table 72. Altor Bioscience Corporation Revenue in Immune Cell Therapy Business (2018-2023) & (US$ Million)
Table 73. Altor Bioscience Corporation Recent Developments
Table 74. Cellectis Company Details
Table 75. Cellectis Business Overview
Table 76. Cellectis Immune Cell Therapy Product
Table 77. Cellectis Revenue in Immune Cell Therapy Business (2018-2023) & (US$ Million)
Table 78. Cellectis Recent Developments
Table 79. Juno Therapeutics Company Details
Table 80. Juno Therapeutics Business Overview
Table 81. Juno Therapeutics Immune Cell Therapy Product
Table 82. Juno Therapeutics Revenue in Immune Cell Therapy Business (2018-2023) & (US$ Million)
Table 83. Juno Therapeutics Recent Developments
Table 84. Kite Pharma Company Details
Table 85. Kite Pharma Business Overview
Table 86. Kite Pharma Immune Cell Therapy Product
Table 87. Kite Pharma Revenue in Immune Cell Therapy Business (2018-2023) & (US$ Million)
Table 88. Kite Pharma Recent Developments
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Immune Cell Therapy Product
Table 92. Novartis Revenue in Immune Cell Therapy Business (2018-2023) & (US$ Million)
Table 93. Novartis Recent Developments
Table 94. Takara Bio Company Details
Table 95. Takara Bio Business Overview
Table 96. Takara Bio Immune Cell Therapy Product
Table 97. Takara Bio Revenue in Immune Cell Therapy Business (2018-2023) & (US$ Million)
Table 98. Takara Bio Recent Developments
Table 99. Unum Therapeutics Company Details
Table 100. Unum Therapeutics Business Overview
Table 101. Unum Therapeutics Immune Cell Therapy Product
Table 102. Unum Therapeutics Revenue in Immune Cell Therapy Business (2018-2023) & (US$ Million)
Table 103. Unum Therapeutics Recent Developments
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immune Cell Therapy Market Size Growth Rate by Type, 2018 VS 2023 VS 2033 (US$ Million)
Figure 2. Global Immune Cell Therapy Market Share by Type: 2023 VS 2033
Figure 3. T Cell Therapy Features
Figure 4. Natural Killer (NK) Cell Therapy Features
Figure 5. Other Features
Figure 6. Global Immune Cell Therapy Market Size Growth Rate by Application, 2018 VS 2023 VS 2033 (US$ Million)
Figure 7. Global Immune Cell Therapy Market Share by Application: 2023 VS 2033
Figure 8. Stomach Cancer Case Studies
Figure 9. Lung Cancer Case Studies
Figure 10. Colorectal Cancer Case Studies
Figure 11. Esophageal Cancer Case Studies
Figure 12. Pancreatic Cancer Case Studies
Figure 13. Other Case Studies
Figure 14. Immune Cell Therapy Report Years Considered
Figure 15. Global Immune Cell Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Immune Cell Therapy Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 17. Global Immune Cell Therapy Market Share by Region: 2023 VS 2033
Figure 18. Global Immune Cell Therapy Market Share by Players in 2023
Figure 19. Global Top Immune Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Cell Therapy as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Immune Cell Therapy Revenue in 2023
Figure 21. North America Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Immune Cell Therapy Market Share by Type (2018-2033)
Figure 23. North America Immune Cell Therapy Market Share by Application (2018-2033)
Figure 24. North America Immune Cell Therapy Market Share by Country (2018-2033)
Figure 25. United States Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Immune Cell Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 28. Europe Immune Cell Therapy Market Share by Type (2018-2033)
Figure 29. Europe Immune Cell Therapy Market Share by Application (2018-2033)
Figure 30. Europe Immune Cell Therapy Market Share by Country (2018-2033)
Figure 31. Germany Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. France Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. U.K. Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Italy Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Russia Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Nordic Countries Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. China Immune Cell Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 38. China Immune Cell Therapy Market Share by Type (2018-2033)
Figure 39. China Immune Cell Therapy Market Share by Application (2018-2033)
Figure 40. Asia Immune Cell Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 41. Asia Immune Cell Therapy Market Share by Type (2018-2033)
Figure 42. Asia Immune Cell Therapy Market Share by Application (2018-2033)
Figure 43. Asia Immune Cell Therapy Market Share by Region (2018-2033)
Figure 44. Japan Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. South Korea Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. China Taiwan Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Southeast Asia Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. India Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Australia Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Immune Cell Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Immune Cell Therapy Market Share by Type (2018-2033)
Figure 52. Middle East, Africa, and Latin America Immune Cell Therapy Market Share by Application (2018-2033)
Figure 53. Middle East, Africa, and Latin America Immune Cell Therapy Market Share by Country (2018-2033)
Figure 54. Brazil Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Mexico Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Turkey Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Saudi Arabia Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Israel Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. GCC Countries Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. Adaptimmune Revenue Growth Rate in Immune Cell Therapy Business (2018-2023)
Figure 61. Altor Bioscience Corporation Revenue Growth Rate in Immune Cell Therapy Business (2018-2023)
Figure 62. Cellectis Revenue Growth Rate in Immune Cell Therapy Business (2018-2023)
Figure 63. Juno Therapeutics Revenue Growth Rate in Immune Cell Therapy Business (2018-2023)
Figure 64. Kite Pharma Revenue Growth Rate in Immune Cell Therapy Business (2018-2023)
Figure 65. Novartis Revenue Growth Rate in Immune Cell Therapy Business (2018-2023)
Figure 66. Takara Bio Revenue Growth Rate in Immune Cell Therapy Business (2018-2023)
Figure 67. Unum Therapeutics Revenue Growth Rate in Immune Cell Therapy Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Global Immune Cell Therapy Market Insights, Forecast to 2034

Global Immune Cell Therapy Market Insights, Forecast to 2034

By Company

Segment by Application

Chapter Outline

Table of Content

List of Figure

Select User License

$4200 Single Licence

$6000 Enterprise Licence

$9100 Corporate Licence

Note : All prices in USD

FAQ'S

User License?

Delivery Time?

How do I place an order?

What is the Payment Options?

Is there a discount for multiple purchases?

Mode of Report Delivery?

Top Industries